Skip to content

Cognitive Behavioral Therapy for Insomnia in Schizophrenia

The Effect of Cognitive Behavioral Therapy for Insomnia on Sleep and Psychotic Symptoms in Schizophrenia Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003224
Enrollment
62
Registered
2018-09-28
Start date
2015-07-13
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Participants received either group CBT-I (CBT-I group) or no intervention (control group) for insomnia. The allocation was proceeded by the CBT-I therapist and blinded to the evaluator. P

Sponsors

Seoul Metropolitan Eunpyeong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants were considered for inclusion if they met the following criteria: 1) diagnosed with schizophrenia according to the Diagnostic And Statistical Manual Of Mental Disorders, 5th edition , 2) active delusions or hallucinations persisting for the past = 3 months assessed by a psychiatrist through clinical interview 3) a total score of The Insomnia Severity Index = 15, 4) aged between 18 and 65 years, and 5) had no change in psychotropic medication dosage over the past month.

Exclusion criteria

Exclusion criteria: Excluded patients were those who, 1) had been diagnosed with sleep apnea, alcohol or substance use disorder, organic syndrome, or intellectual disability, and 2) were currently participating in individual cognitive behavioral therapy.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures used in this study were the total scores of the Insomnia Severity Index and Pittsburgh Sleep Quality Index.

Secondary

MeasureTime frame
Psychotic Symptoms Rating Scale, Anxiety Sensitivity Index, and Beck Depression Inventory were used for to evaluate changes in psychotic symptoms, anxiety symptoms, and depressive symptoms, respectively.

Countries

Korea, Republic of

Contacts

Public ContactYu-Jin Lee

Seoul Metropolitan Eunpyeong Hospital

gginadoc@gmail.com+82-2-300-8317

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026